Is ACCS or CDLX more undervalued in 2026?

CirclFi compares ACCESS Newswire Inc. (ACCS) and Cardlytics, Inc. Common Stock (CDLX) using 13 institutional-grade valuation models. ACCS has a Quality of Company score of 8.5/10 while CDLX scores 4.3/10.

Which is a better buy — ACCS or CDLX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ACCS and CDLX valuations compare?

ACCS at $6.32 and CDLX at $0.71 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ACCS vs CDLX Valuation Comparison 2026 — Intrinsic Value Analysis

ACCS

Advertising Agencies

ACCESS Newswire Inc.

Quality

8.5

out of 10

Value Trap

LOW

Price

$6.32

Last close

Models

12/13

Active

CDLX

Advertising Agencies

Cardlytics, Inc. Common Stock

Quality

4.3

out of 10

Value Trap

LOW

Price

$0.71

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	ACCS Fair Value	ACCS Upside	CDLX Fair Value	CDLX Upside
Bayesian DCF	Intrinsic	$5.21	-17.6%	$0.81	+33.8%
Earnings Power Value	Intrinsic	$11.71	+41.6%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$8.36	+32.2%	$2.69	+277.3%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ACCS vs CDLX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ACCS vs CDLX — Which Stock Is More Undervalued?

ACCS scores higher with a 8.5/10 quality rating vs CDLX's 4.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing ACCESS Newswire Inc. (ACCS) and Cardlytics, Inc. Common Stock (CDLX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ACCS currently trades at $6.32 with a QOC of 8.5/10, while CDLX trades at $0.71 with a QOC of 4.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).